WHO ICTRP trial
XED-60 in the treatment of dry eye, Phase2 study.
JPRN-jRCT1080222777 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT1080222777 |
|---|---|
| Public title | XED-60 in the treatment of dry eye, Phase2 study. |
| Scientific title | XED-60 in the treatment of dry eye, Phase2 study. |
| Primary sponsor | Lion Corporation |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Dry eye |
| Interventions | investigational material(s) Generic name etc : XED-60 INN of investigational material : Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for Investigational material : Instillation, 6times/day for 4weeks… |
| Registration date | Mar 3, 2015 |
| Target size | 60 |
| Secondary IDs | JapicCTI-152829 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: